Acadia Healthcare Company Inc (NASDAQ:ACHC) – Research analysts at William Blair dropped their Q4 2018 earnings estimates for shares of Acadia Healthcare in a research report issued on Tuesday, November 6th. William Blair analyst R. Daniels now anticipates that the company will post earnings of $0.32 per share for the quarter, down from their prior estimate of $0.62. William Blair also issued estimates for Acadia Healthcare’s Q3 2019 earnings at $0.71 EPS.
Acadia Healthcare (NASDAQ:ACHC) last posted its quarterly earnings results on Monday, November 5th. The company reported $0.55 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.64 by ($0.09). The company had revenue of $760.90 million for the quarter, compared to the consensus estimate of $760.46 million. Acadia Healthcare had a net margin of 7.43% and a return on equity of 7.71%. Acadia Healthcare’s quarterly revenue was up 6.2% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.58 EPS.
Several other equities analysts have also weighed in on the stock. Craig Hallum lowered shares of Acadia Healthcare from a “buy” rating to a “hold” rating in a research report on Wednesday, October 17th. They noted that the move was a valuation call. BidaskClub upgraded shares of Acadia Healthcare from a “strong sell” rating to a “sell” rating in a research report on Saturday, October 6th. Mizuho set a $37.00 target price on shares of Acadia Healthcare and gave the stock a “hold” rating in a research report on Tuesday, August 28th. Cantor Fitzgerald reiterated a “hold” rating and set a $39.00 target price on shares of Acadia Healthcare in a research report on Thursday, October 18th. Finally, ValuEngine upgraded shares of Acadia Healthcare from a “strong sell” rating to a “sell” rating in a research report on Thursday, October 18th. Eight investment analysts have rated the stock with a hold rating and four have given a buy rating to the company’s stock. The company has a consensus rating of “Hold” and a consensus price target of $43.11.
ACHC opened at $42.50 on Thursday. The stock has a market cap of $3.61 billion, a P/E ratio of 17.19, a P/E/G ratio of 1.61 and a beta of 0.22. The company has a debt-to-equity ratio of 1.19, a current ratio of 1.26 and a quick ratio of 1.24. Acadia Healthcare has a fifty-two week low of $26.92 and a fifty-two week high of $45.35.
In other Acadia Healthcare news, Director Reeve B. Waud sold 41,865 shares of the firm’s stock in a transaction on Thursday, November 1st. The stock was sold at an average price of $45.00, for a total transaction of $1,883,925.00. Following the completion of the transaction, the director now owns 14,213 shares of the company’s stock, valued at $639,585. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Insiders own 11.10% of the company’s stock.
A number of institutional investors have recently made changes to their positions in ACHC. Alpine Woods Capital Investors LLC purchased a new position in shares of Acadia Healthcare in the 2nd quarter worth about $153,000. New Jersey Better Educational Savings Trust purchased a new position in shares of Acadia Healthcare in the 2nd quarter worth about $205,000. Bbva Compass Bancshares Inc. purchased a new position in shares of Acadia Healthcare in the 2nd quarter worth about $259,000. Strs Ohio purchased a new position in shares of Acadia Healthcare in the 3rd quarter worth about $308,000. Finally, BNP Paribas Arbitrage SA raised its position in shares of Acadia Healthcare by 118.3% in the 2nd quarter. BNP Paribas Arbitrage SA now owns 8,425 shares of the company’s stock worth $345,000 after purchasing an additional 4,566 shares during the last quarter.
About Acadia Healthcare
Acadia Healthcare Company, Inc develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities, and outpatient behavioral healthcare facilities to serve the behavioral health and recovery needs of communities. The company operates acute inpatient psychiatric facilities, which offer evaluation and crisis stabilization of patients with severe psychiatric diagnoses; specialty treatment facilities, including residential recovery facilities, eating disorder facilities, and comprehensive treatment centers that provide continuum care for adults with addictive disorders and co-occurring mental disorders; and residential treatment centers, which treat patients with behavioral disorders in a non-hospital setting, including outdoor programs.
Further Reading: Should I invest in “strong buy” stocks?
Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.